Patents Assigned to Hutchison
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 8987269
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: March 24, 2015
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
    Patent number: 8946249
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: February 3, 2015
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Hong Jia, Yumin Cui, Yongxin Ren, Yang Sai, Zhenping Wu, Wenji Li, Jiangyong Shao, Zhenping Tian
  • Pyrimidine derivatives
    Patent number: 8901143
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5, T, U, V, X, Y, Z, G, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder, e.g., cancer or age-related macular degeneration, with such a compound.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: December 2, 2014
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Weihan Zhang, Yumin Cui, Xiaoqiang Yan, Yongxin Ren, Jifeng Duan, Yang Sai
  • COMPOUND, CERTAIN NOVEL FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE
    Publication number: 20140200232
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Application
    Filed: December 12, 2013
    Publication date: July 17, 2014
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: WEI-GUO SU, WEIHAN ZHANG, HONG JIA, YUMIN CUI, YONGXIN REN, YANG SAI, ZHENPING WU, WENJI LI, JIANGYONG SHAO, ZHENPING TIAN
  • SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
    Publication number: 20140121200
    Abstract: Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
    Type: Application
    Filed: June 7, 2012
    Publication date: May 1, 2014
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jianguo Ji
  • Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
    Patent number: 8658658
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: February 25, 2014
    Assignee: Hutchison MediPharma Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Hong Jia, Yumin Cui, Yongxin Ren, Yang Sai, Zhenping Wu, Wenji Li, Jiangyong Shao, Zhenping Tian
  • QUINAZOLINE DERIVATIVES
    Publication number: 20130217661
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, X, Y, and Z are defined herein. It also discloses a method of treating cancer with one of these compounds.
    Type: Application
    Filed: March 18, 2013
    Publication date: August 22, 2013
    Applicant: HUTCHISON MEDIPHARMA ENTERPRISES LIMITED
    Inventor: Hutchison Medipharma Enterprises Limited
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 8507487
    Abstract: Provided are certain triazolopyridines and triazolopyrazines of Formula 1. wherein X, Y, R1, R2, R3, R4 and R5 have any of the meanings described herein; processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: August 13, 2013
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Pyrimidinyl indole compounds
    Patent number: 8501166
    Abstract: The present invention provides pyrimidinyl indole compounds as novel kinase inhibitors for the treatment of cancer and inflammatory diseases.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: August 6, 2013
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Jinshui Li
  • Use of substituted quinazoline compounds in treating age-related macular degeneration
    Patent number: 8497372
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: July 30, 2013
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • QUINAZOLINE COMPOUNDS
    Publication number: 20130172373
    Abstract: Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).
    Type: Application
    Filed: May 25, 2011
    Publication date: July 4, 2013
    Applicant: Hutchison Medipharma Limited
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • Traffic signal with integrated sensors
    Patent number: 8466962
    Abstract: An apparatus for integrating sensors with a traffic signal. A camera is operably disposed within a housing. The housing is attached to an object such that the camera can observe traffic flowing past a traffic signal. A visor is attached to the housing such that an optical aperture of the camera is covered by the visor, wherein the visor comprises a roof having an angle that slopes, relative to the housing, towards the optical aperture, wherein the visor further comprises a floor connected to the roof, and wherein the floor extends outwardly from the housing.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: June 18, 2013
    Assignee: M&K Hutchison Investments, LP
    Inventor: Michael Cole Hutchison
  • Quinazoline derivatives
    Patent number: 8426430
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, X, Y, and Z are defined herein. It also discloses a method of treating cancer with one of these compounds.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: April 23, 2013
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • PYRIMIDINYL INDOLE COMPOUNDS
    Publication number: 20130058892
    Abstract: The present invention provides pyrimidinyl indole compounds as novel kinase inhibitors for the treatment of cancer and inflammatory diseases.
    Type: Application
    Filed: April 27, 2010
    Publication date: March 7, 2013
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Jinshui Li
  • ANDROGRAPHIS PANICULATA EXTRACT
    Publication number: 20130023493
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: September 11, 2012
    Publication date: January 24, 2013
    Applicant: HUTCHISON MEDIPHARMA ENTERPRISES LIMITED
    Inventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
  • Pyrimidine derivatives
    Patent number: 8349859
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5, T, U, V, X, Y, Z, G, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder, e.g., cancer or age-related macular degeneration, with such a compound.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: January 8, 2013
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Weihan Zhang, Yumin Cui, Xiaoqiang Yan, Yongxin Ren, Jifeng Duan, Yang Sai
  • Mobile communication device providing integrated access to telephony and internet
    Patent number: 8274966
    Abstract: Provided are devices, methods, communication managers and user interface solutions that enable access to multiple services from a mobile communications device. A mobile communication device that provides telephony services via a PSTN also includes multiple communication channels that exploit packet data transfer via an IP network, for example enabling VoIP, instant messaging and other internet-based communication services to be initiated from a mobile telephone.
    Type: Grant
    Filed: October 13, 2008
    Date of Patent: September 25, 2012
    Assignee: Hutchison Whampoa Three G IP (Bahamas) Limited
    Inventors: Christopher Henry Seal, Gaetano Vitolo, Kevin David Joyce, Nadir El Yakhlifi
  • Use of substituted quinazoline compounds in treating angiogenesis-related diseases
    Patent number: 8212033
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: July 3, 2012
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • Crude extracts from andrographis paniculata
    Patent number: RE42718
    Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.
    Type: Grant
    Filed: March 4, 2010
    Date of Patent: September 20, 2011
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
  • Crude extracts from
    Patent number: RE43423
    Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.
    Type: Grant
    Filed: July 22, 2011
    Date of Patent: May 29, 2012
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai